Statement on the prophylaxis of severe RSV diseases using palivizumab in at risk children

被引：0
|
作者：
机构：
来源：
MONATSSCHRIFT KINDERHEILKUNDE | 2007年 / 155卷 / 07期
关键词：
D O I：
10.1007/s00112-007-1541-6
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：649 / 652
页数：4
相关论文
共 50 条
  • [41] Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab
    Mulot, Gwenaelle
    Benchaib, Mehdi
    Plaisant, Frank
    Ploin, Dominique
    Gillet, Yves
    Javouhey, Etienne
    Claris, Olivier
    Picaud, Jean-Charles
    Casalegno, Jean-Sebastien
    Butin, Marine
    VRS Study Grp Lyon
    [J]. FRONTIERS IN PEDIATRICS, 2022, 10
  • [42] Genetic polymorphisms of adhesion molecules in children with severe RSV-associated diseases
    Krueger, M.
    Puthothu, B.
    Heinze, J.
    Forster, J.
    Heinzmann, A.
    [J]. INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2006, 33 (04) : 233 - 235
  • [43] Emotional and time costs of respiratory syncytial virus prophylaxis: Comparing palivizumab to RSV-IG
    Robbins, JM
    Tilford, JM
    Gillaspy, SR
    Simpson, DD
    Wheeler, JG
    Shaw, JL
    Jacobs, RF
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 221A - 221A
  • [44] An outpatient program for administration of palivizumab prophylaxis for respiratory syncitial virus (RSV) in a subacute pediatric hospital
    Gonzalez, F
    Ballard, D
    Hirsch, D
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 218A - 218A
  • [45] Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
    Caserta, Mary T.
    O'Leary, Sean T. R.
    Munoz, Flor M. M.
    Ralston, Shawn L.
    [J]. PEDIATRICS, 2023, 152 (01)
  • [46] Cardiac children under 2 years with haemodynamically significant vitium need an RSV prophylaxis with Palivizumab - rational and evidence-based recommendations
    Eyermann, R.
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (09) : 684 - 684
  • [47] Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenital Heart Disease
    Ruey-Kang R. Chang
    Alex Y. Chen
    [J]. Pediatric Cardiology, 2010, 31 : 90 - 95
  • [48] Three year experience with a coordinated neonatal and general pediatric practice Palivizumab prophylaxis program that prevents RSV hospitalization of high risk infants
    Frogel, MP
    Nerwen, C
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 167A - 167A
  • [49] Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenital Heart Disease
    Chang, Ruey-Kang R.
    Chen, Alex Y.
    [J]. PEDIATRIC CARDIOLOGY, 2010, 31 (01) : 90 - 95
  • [50] Appropriate prophylaxis with restrictive palivizumab regimen in preterm children in Sweden
    Navér, L
    Eriksson, M
    Ewald, U
    Linde, A
    Lindroth, M
    Schollin, J
    [J]. ACTA PAEDIATRICA, 2004, 93 (11) : 1470 - 1473
12345